SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : VVUS: VIVUS INC. (NASDAQ)

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Colby who wrote (3404)12/11/1997 2:38:00 PM
From: LoLoLoLita  Read Replies (2) of 23519
 
Colby, the mgmt. DID WARN about just exactly this kind of
problem in ramping up production. It's all in the last 10-Q.
----------
The Company has limited experience in manufacturing and
selling MUSE (alprostadil) in commercial quantities.
Since the commercial launch of MUSE (alprostadil) in
January 1997, the Company has experienced product
shortages due to higher than expected demand and
difficulties encountered in scaling up production of MUSE (alprostadil). The Company has initiated the build out of
90,000 square feet of additional manufacturing space, and
it is currently seeking a location for construction of a
European manufacturing operation. If the Company encounters
further difficulties with its current manufacturing facility
or delays in completion or regulatory approval of its new
manufacturing facility, capacity constraints could continue
for an extended period of time, which would have a material
adverse effect on the Company's business, financial condition
and results of operations.
----------

Hopefully, we won't have any stupid cry-baby lawsuits
against VVUS by people who didn't do their DD, and
didn't read the SEC filings.

Cheers, David
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext